Nicotine and cognition in young and aged nonhuman primates

Jerry J. Buccafusco, Alvin V Terry

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Citations (Scopus)

Abstract

The earliest studies that sought to examine the ability of nicotine to enhance cognitive performance were performed in rodents, and many of these experiments were predicated on the known alerting or nootropic effect of certain CNS stimulant drugs. We entered this area in 1988 and chose to study the potential cognitive-enhancing actions of nicotine in nonhuman primates with the premise that nicotine’s actions involved more complex mechanisms than a nonspecific sharpening of attention or arousal. Interest was based largely on two findings. In studying the effects of nicotine in humans 2 years earlier, Wesnes and Warburton concluded that nicotine facilitates state-dependent learning and does not affect associative processes. Secondly, the strong relationship between the ability of the centrally acting nicotinic receptor antagonist mecamylamine to impair performance of the retention trial of an inhibitory avoidance task in rats, and its ability to inhibit the biosynthesis of acetylcholine in cortical and limbic structures was impressive.

Original languageEnglish (US)
Title of host publicationNicotinic Receptors in the Nervous System
PublisherCRC Press
Pages179-198
Number of pages20
ISBN (Electronic)9781420038521
ISBN (Print)084932386X, 9780849323867
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Nicotine
Cognition
Primates
Aptitude
Nicotinic Antagonists
Nootropic Agents
Mecamylamine
Nicotinic Receptors
Arousal
Acetylcholine
Rodentia
Learning
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Buccafusco, J. J., & Terry, A. V. (2001). Nicotine and cognition in young and aged nonhuman primates. In Nicotinic Receptors in the Nervous System (pp. 179-198). CRC Press.

Nicotine and cognition in young and aged nonhuman primates. / Buccafusco, Jerry J.; Terry, Alvin V.

Nicotinic Receptors in the Nervous System. CRC Press, 2001. p. 179-198.

Research output: Chapter in Book/Report/Conference proceedingChapter

Buccafusco, JJ & Terry, AV 2001, Nicotine and cognition in young and aged nonhuman primates. in Nicotinic Receptors in the Nervous System. CRC Press, pp. 179-198.
Buccafusco JJ, Terry AV. Nicotine and cognition in young and aged nonhuman primates. In Nicotinic Receptors in the Nervous System. CRC Press. 2001. p. 179-198
Buccafusco, Jerry J. ; Terry, Alvin V. / Nicotine and cognition in young and aged nonhuman primates. Nicotinic Receptors in the Nervous System. CRC Press, 2001. pp. 179-198
@inbook{c1e6af6bc7c345a18756c1add3080c8d,
title = "Nicotine and cognition in young and aged nonhuman primates",
abstract = "The earliest studies that sought to examine the ability of nicotine to enhance cognitive performance were performed in rodents, and many of these experiments were predicated on the known alerting or nootropic effect of certain CNS stimulant drugs. We entered this area in 1988 and chose to study the potential cognitive-enhancing actions of nicotine in nonhuman primates with the premise that nicotine’s actions involved more complex mechanisms than a nonspecific sharpening of attention or arousal. Interest was based largely on two findings. In studying the effects of nicotine in humans 2 years earlier, Wesnes and Warburton concluded that nicotine facilitates state-dependent learning and does not affect associative processes. Secondly, the strong relationship between the ability of the centrally acting nicotinic receptor antagonist mecamylamine to impair performance of the retention trial of an inhibitory avoidance task in rats, and its ability to inhibit the biosynthesis of acetylcholine in cortical and limbic structures was impressive.",
author = "Buccafusco, {Jerry J.} and Terry, {Alvin V}",
year = "2001",
month = "1",
day = "1",
language = "English (US)",
isbn = "084932386X",
pages = "179--198",
booktitle = "Nicotinic Receptors in the Nervous System",
publisher = "CRC Press",

}

TY - CHAP

T1 - Nicotine and cognition in young and aged nonhuman primates

AU - Buccafusco, Jerry J.

AU - Terry, Alvin V

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The earliest studies that sought to examine the ability of nicotine to enhance cognitive performance were performed in rodents, and many of these experiments were predicated on the known alerting or nootropic effect of certain CNS stimulant drugs. We entered this area in 1988 and chose to study the potential cognitive-enhancing actions of nicotine in nonhuman primates with the premise that nicotine’s actions involved more complex mechanisms than a nonspecific sharpening of attention or arousal. Interest was based largely on two findings. In studying the effects of nicotine in humans 2 years earlier, Wesnes and Warburton concluded that nicotine facilitates state-dependent learning and does not affect associative processes. Secondly, the strong relationship between the ability of the centrally acting nicotinic receptor antagonist mecamylamine to impair performance of the retention trial of an inhibitory avoidance task in rats, and its ability to inhibit the biosynthesis of acetylcholine in cortical and limbic structures was impressive.

AB - The earliest studies that sought to examine the ability of nicotine to enhance cognitive performance were performed in rodents, and many of these experiments were predicated on the known alerting or nootropic effect of certain CNS stimulant drugs. We entered this area in 1988 and chose to study the potential cognitive-enhancing actions of nicotine in nonhuman primates with the premise that nicotine’s actions involved more complex mechanisms than a nonspecific sharpening of attention or arousal. Interest was based largely on two findings. In studying the effects of nicotine in humans 2 years earlier, Wesnes and Warburton concluded that nicotine facilitates state-dependent learning and does not affect associative processes. Secondly, the strong relationship between the ability of the centrally acting nicotinic receptor antagonist mecamylamine to impair performance of the retention trial of an inhibitory avoidance task in rats, and its ability to inhibit the biosynthesis of acetylcholine in cortical and limbic structures was impressive.

UR - http://www.scopus.com/inward/record.url?scp=79958296476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958296476&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:79958296476

SN - 084932386X

SN - 9780849323867

SP - 179

EP - 198

BT - Nicotinic Receptors in the Nervous System

PB - CRC Press

ER -